Cross-fund · 1 holders
PHAR
PHARMING GROUP NV
CUSIP 71716E105
1
Tracked holders
$169,545
Aggregate value
10,189
Shares
2
Active funds
Funds holding PHAR
| Fund | Strategy | Period | Value | % of book | Δ shares | Status |
|---|---|---|---|---|---|---|
| Citadel | Multi-Strategy | Q1 2026 | $169,545 | — | -7,501 | -42.4% |
| Millennium | Multi-Strategy | Q1 2026 | — | — | -20,385 | EXITED |
Aggregated from the latest 13F-HR per tracked fund (longs only). QoQ deltas compare against each fund's prior quarterly filing.